June 23, 2020
1 min read

Arazlo lotion launched in US for acne treatment

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Arazlo lotion has been released for commercial distribution in the United States, Ortho Dermatologics announced in a press release.

The first tazarotene acne treatment available in lotion formulation, Arazlo (tazarotene 0.045%) was approved by the FDA in December 2019.

“Retinoids like tazarotene are highly effective in treating acne and considered a cornerstone of acne treatment, but often are perceived to be associated with skin irritation. Clinical studies have demonstrated that Arazlo’s proprietary formulation provides the proven efficacy of a retinoid in a lotion that is more tolerable to patients than a higher concentration tazarotene,” Bill Humphries, president of Ortho Dermatologics, said in the release.

The medication is available via prescription for people aged 9 and older with acne. Its price is comparable to other branded acne products, according to the release.